Announcements

The George Washington University (GW) School of Medicine and Health Sciences (SMHS) is pleased to announce that Stephanie Sarandos, MA, has been selected to serve as the assistant dean for evaluation. In this role, Sarandos will be responsible for all aspects of MD program evaluation, ensuring the…

Pfizer has launched a Phase 3 study of its RSV vaccine candidate and researchers at the George Washington University are studying the vaccine’s safety and ability to trigger an immune response in two groups of people at risk for severe illness caused by respiratory syncytial virus or RSV.

As of 2021 it is estimated that world-wide the number of refugees and asylum-seekers is over 31 million. While academics and researchers have been attempting to capture global and domestic attitudes towards these vulnerable groups, many of these studies will report biased findings and influence…

The GW School of Medicine and Health Sciences is pleased to announce that Edward M. Barksdale, MD, FACS, FAAS, surgeon in chief, University Hospitals Rainbow Babies & Children’s Hospital will be the keynote speaker for the 2023 GW MD Graduation and Diploma Ceremony on May 21, 2023, in Lisner…

George Washington University (GW) is excited to share that it launched its chapter of the National Academy of Inventors (NAI) on the 26th of April, 2023. The NAI is an esteemed organization that honors academic inventors and acknowledges the impact of their groundbreaking discoveries on society,…

The Office of International Medicine Programs (IMP) at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) has just initiated a six-year contract with Ibn Sina University for Medical Sciences (ISUMS), the first private medical school in Amman, Jordan.

Mohamad Koubeissi, MD, FAAN, FANA, FAES, professor of neurology, has been selected to serve as interim chair of the Department of Neurology and Rehabilitation Medicine. Out-going Department Chair Henry Kaminski, MD, will continue to serve the academic medical enterprise in several missions.

A pair of Phase III trials led by Jonathan I. Silverberg, MD, PhD, suggest a 16-week treatment with a drug called lebrikizumab was effective in adults and adolescents with moderate to severe dermatitis. The study results were published in the March 15 edition of the New England Journal of Medicine.

George Washington University School of Medicine and Health Sciences Department of Dermatology faculty, residents, and students have a large-scale, high-impact presence during the 2023 American Academy of Dermatology (AAD) Meeting, March 17–21 in New Orleans, Louisiana.

Elmer Huerta, MD, MPH, director of the Cancer Preventorium at the George Washington University Cancer Center, has been invited to participate in the White House Cancer Moonshot Colorectal Cancer Forum.